FDA Approves First-of-its-kind Device to Treat Heart Failure Patients

by Iswarya on  March 23, 2019 at 10:04 AM Heart Disease News
RSS Email Print This Page Comment bookmark
Font : A-A+

Food and Drug Administration (FDA) of the US has approved a new device called the Optimizer Smart system for treating patients with chronic, life-threatening heart failure. This device addresses the unmet need of patients who are not able to receive treatment with other heart failure devices.
FDA Approves First-of-its-kind Device to Treat Heart Failure Patients
FDA Approves First-of-its-kind Device to Treat Heart Failure Patients

The Optimizer Smart system is comprised of several components, including an implantable pulse generator, battery charger, programmer and software. The pulse generator is implanted under the skin in the upper left or right area of the chest and connected to three leads that are implanted in the heart.

After the device is implanted, a physician tests and programmes the device, which delivers electrical impulses to the heart during regular heartbeats to help improve the heart's squeezing capability.

The device would be beneficial for patients not suited to treatment with other heart failure devices such as cardiac resynchronization therapy to restore a normal timing pattern of the heartbeat, the US FDA noted in a statement.

"Patients with moderate-to-severe chronic heart failure have limited treatment options. And for those who are unable to be treated due to underlying conditions or who have not responded to available treatments, their quality of life may be impacted, with limits on the types of physical activities they can do," said Bram Zuckerman, Director at FDA's Centre for Devices and Radiological Health.

"The FDA recognized the unmet need for these patients and worked with the manufacturer...to efficiently bring this product to market while ensuring it meets our regulatory requirements for safety and effectiveness," Zuckerman added.

For the study, the US FDA evaluated data from two clinical trials with a total of 389 patients with moderate-to-severe heart failure.

All patients received optimal medical therapy, and 191 patients also received an Optimizer Smart system implant.

The Optimizer Smart system improves the quality of life and functional status of certain heart failure patients.

The health body has granted approval of the Optimizer Smart system to US-based Impulse Dynamics.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

Recommended Reading

More News on:

Congenital Heart Disease Heart Healthy Heart Pulmonary Arterial Hypertension Statins Mitral Valve Prolapse Aortic Valve Stenosis Infective Endocarditis Cough Symptom Evaluation Pericarditis 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive